 SEATTLE--BUSINESS WIRE--Alpine Immune Sciences, Inc. NASDAQ: ALPN, a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced that members of its management team will participate at the following investor conferences in March 2022: Cowens 42nd Annual Health Care Conference Date: Monday, March 7, 2022 Time: 2:50 p.m. ET11:50 a.m. PT Event: Fireside Chat Oppenheimer 32nd Annual Healthcare Co 